Epidemiologic Cohort Study of Interstitial Cystitis
Agency: Centers for Disease Control and Prevention - ERA
- 93.283 -- Centers for Disease Control and Prevention Investigations and Technical Assistance
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The primary purpose of this funding opportunity is to follow a well-defined cohort of participants with interstitial cystitis (IC) in order to obtain incidence estimates of IC, define the demographic and clinical patterns of IC, and document its longitudinal impact on the health of affected people over time. In addition, the focus of this Notice of Funding Opportunity (NOFO) will include translating the scientific knowledge on IC, extracted from this and prior studies, to support public health practice, including: (1) patient strategies for improving quality of life, (2) provider and patient awareness and education, and (3) medical and self-management of IC. This funding opportunity should be used to help strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC.
Eligibility
Eligible applicants
Government
- County governments
- Federally recognized Native American tribal governments
- State governments
- Special district governments
- City or township governments
- Public and Indian housing authorities
Nonprofit
- Other Native American tribal organizations
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Business
- For-profit organizations other than small businesses
- Small businesses
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
Grants Policy
Documents
| File name | Description | Last updated |
|---|---|---|
| QA_Potential_Applicant_Questions_1-7-2021.pdf | Q&A's For RFA-DP-21-002 | Jan 7, 2021 04:36 PM UTC |
| DP21-002_Final_NOFO_11_13_2020_pdf.pdf | Epidemiologic Cohort Study of Interstitial Cystitis | Nov 13, 2020 06:23 PM UTC |
Link to additional information
--
Archived: February 18, 2021
Award
$2,490,000
Program Funding
1
Expected awards
$--
Award Minimum
$900,000
Award Maximum
Funding opportunity number:
RFA-DP-21-002
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
9
Posted date:
November 10, 2020
Archive date:
February 18, 2021
